Factors determining performance of bronchodilator reversibility tests in middle-aged and elderly

Respiratory Medicine

Volumn 98, Issue 11, 2004, Pages 1071-1079

  Lehmann, Sverre ^a   Vollset, Stein E ^a   Nygaard, Harald A ^b   Gulsvik, Amund ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Age; Cognitive aspects; Cross sectional studies; Respiratory symptoms; Spirometry

Indexed keywords

BRONCHODILATING AGENT; SALBUTAMOL;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CIGARETTE SMOKING; COGNITIVE DEFECT; COMMUNITY CARE; CONTROLLED STUDY; DATA ANALYSIS; EDUCATION; FEMALE; FORCED EXPIRATORY VOLUME; GENDER; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NORWAY; PERFORMANCE; PREDICTION; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZATION; RELIABILITY; RESPIRATORY TRACT DISEASE; RISK FACTOR; SAMPLING; SPIROMETRY; SYMPTOMATOLOGY;

ADRENERGIC BETA-AGONISTS; AGED; ANTHROPOMETRY; ASTHMA; BRONCHODILATOR AGENTS; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; EDUCATIONAL STATUS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; SPIROMETRY;

EID: 4844220069     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2004.03.019     Document Type: Article

References (40)

1. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD), Pauwels RA, Buist S, Calverley PMA, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1256-76. Internet address: http://www.goldcopd.com
2. Hansen E.F. Phanareth K. Laursen L.C. Kok-Jensen A. Dirksen A. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease Am J Respir Crit Care Med 159 1999 1267-1271
3. Postma D.S. Gimeno F. van der Weele L.T. Sluiter H.J. Assessment of ventilatory variables in survival prediction of patients with chronic airflow obstruction: the importance of reversibility Eur J Respir Dis 67 1985 360-368
4. Traver G.A. Cline M.G. Burrows B. Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study Am Rev Respir Dis 119 1979 895-902
5. Anthonisen N.R. Wright E.C. Hodgkin J.E. Prognosis in chronic obstructive pulmonary disease Am Rev Respir Dis 133 1986 14-20
6. Hankinson J.L. Bang K.M. Acceptability and reproducibility criteria of the American Thoracic Society as observed in a sample of the general population Am Rev Respir Dis 143 1991 516-521
7. Humerfelt S. Eide G.E. Kvåle G. Gulsvik A. Predictors of spirometric test failure: a comparison of the 1983 and 1993 acceptability criteria from the European Community for Coal and Steel Occup Environ Med 52 1995 547-553
8. Ng'Ang'a L.W. Ernst P. Jaakkola M.S. Gerardi G. Hanley J.H. Becklake M.R. Spirometric lung function. Distribution and determinants of test failure in a young adult population Am Rev Respir Dis 145 1992 48-52
9. Eisen E.A. Dockery D.W. Speizer F.E. Fay M.E. Ferris B.G. Jr. The association between health status and the performance of excessively variable spirometry tests in a population-based study in six US cities Am Rev Respir Dis 136 1987 1371-1376
10. Lorber D.B. Kaltenborn W. Burrows B. Responses to isoproterenol in a general population sample Am Rev Respir Dis 118 1978 855-861
11. Dales R.E. Spizer W.O. Tousignant P. Schechter M. Suissa S. Clinical interpretation of airway response to a bronchodilator; epidemiologic considerations Am Rev Respir Dis 138 1988 317-320
12. Nygård O. Vollset S.E. Refsum H. Stensvold I. Tverdal Å. Nordrehaug J.E. Ueland P.M. Kvåle G. Total plasma homocystein and cardiovascular risk profile. The Hordaland Homocysteine Study JAMA 274 1995 1526-1533
13. 1 and airflow limitation related to occupational exposures in men of an urban community Eur Respir J 6 1993 1095-1103
14. Pearson M.G. Alderslade R. Allen S.C. BTS Guidelines for the management of chronic obstructive pulmonary disease Thorax 52 1997 S9
15. ATS statement 1994: Standardization of Spirometry. Am J Respir Crit Care Med 1995;152:1107-36.
16. Malton A. Sumby B.S. Smith I.J. A comparison of in vitro drug drug delivery from two multidose powder inhalation devices Eur J Clin Res 7 1995 177-193
17. Braekhus A. Laake K. Engedal K. The Mini-Mental State Examination: identifying the most efficient variables for detecting cognitive impairment in the elderly J Am Geriatr Soc 40 1992 1139-1145
18. The World Health Organization (WHO) Internet address: http://www.who.int/archives/inf-pr-1997/en/pr97-46.html
19. Bakke P.S. Hanoa R. Gulsvik A. Educational level and obstructive lung disease given smoking habits and occupational airborne exposure: a Norwegian community study Am J Epidemiol 141 1995 1080-1088
20. Brogger J.C. Bakke P.S. Gulsvik A. Comparison of respiratory symptoms questionnaires Int J Tuberc Lung Dis 4 2000 83-90
21. Burney P.G.J. Chinn S. Developing a new questionnaire for measuring the prevalence and distribution of asthma Chest 91 1987 79s-83s
22. Gulsvik A. Prevalence and manifestations of obstructive lung disease in the city of Oslo Scand J Resp Dis 60 1979 286-296
23. Bjartveit K. Foss O.P. Gjervig T. Lund-Larsen P.G. The cardiovascular disease study in Norwegian counties Background and organization. Acta Med Scand 634 1979 S1-S70
24. Bakke P. Gulsvik A. Hanoa R. Eide G.E. Smoking habits and lifetime occupational exposure to gases or dusts, including asbestos and quartz, in a Norwegian community Scand J Work Environ Health 16 1990 195-202
25. Gulsvik A. Bakke P. Humerfelt S. Omenaas E. Baste V. Measurements of respiratory symptoms and sample size to detect a given difference between treatment groups in obstructive lung disease Eur Respir Rev 1 1991 436-443
26. 1) and forced vital capacity (FVC) variability in asymptomatic never-smoking men Clin Physiol 18 1998 387-396
27. Eagan T.M.L. Eide G.E. Gulsvik A. Bakke P.S. Non-response in a community cohort study. Predictors and consequences for exposure-disease associations J Clin Epidemiol 55 2002 775-781
28. Bellia V. Pistelli R. Catalano F. Antonelli-Incalzi R. Grassi V. Melillo G. Olivieri D. Rengo F. Quality control of spirometry in the elderly. The SA.R.A study SAlute Respiration nell'Anziano=Respiratory Health in the Elderly Am J Respir Crit Care Med 161 2000 1094-1100
29. Guerra S. Sherrill D.L. Bobadilla A. Martinez F.D. Barbee R.A. The relation of body mass index to asthma, chronic bronchitis, and emphysema Chest 122 2002 1256-1263
30. Cabanes L.R. Weber S.N. Matran R. et al. Bronchial hyperresponsiveness to methacholine in patients with impaired left ventricular function N Engl J Med 320 1989 1317-1322
31. Hyatt R.E. Flath R.E. Relationship of air flow to pressure during maximal respiratory effort in man J Appl Physiol 21 1966 477-482
32. Davies C. Campbell E.J.M. Openshaw P. Pride N.B. Woodroof G. Importance of airway closure in limiting maximal expiration in normal men J Appl Physiol 48 1980 695-701
33. Bakke P. Baste V. Gulsvik A. Bronchial responsiveness in a Norwegian community Am Rev Respir Dis 143 1991 317-322
34. Gayrard P. Orehek J. Grimand C. Charpin J. Bronchoconstrictor effects of a deep inspiration in patients with asthma Am Rev Respir Dis 3 1975 433-439
35. Orehek J. Charpin D. Velardocchio J.M. Frimand C. Bronchomotor effects of bronchoconstriction-induced deep inspirations in asthmatics Am Rev Respir Dis 121 1980 297-305
36. Brand P.L. Quanjer P.H. Postma D.S. Kerstjens H.A. Koeter G.H. Dekhuijzen P.N. Sluiter H.J. Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group Thorax 47 1992 429-436
37. Dompeling E. van Schayck C.P. Molema J. Akkermans R. Folgering H. van Grunsven P.M. van Weel C. A comparison of six different ways of expressing the bronchodilating response in asthma and COPD; reproducibility and dependence of prebronchodilator FEV1 Eur Respir J 5 1992 975-981
38. Calverley P.M. Burge P.S. Spencer S. Anderson J.A. Jones P.W. Bronchodilator reversibility testing in chronic obstructive pulmonary disease Thorax 58 2003 659-664
39. Van Schayck C.P. Loozen J.M. Wagena E. Akkermans R.P. Wesseling G.J. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study Br Med J 324 2002 1370
40. Van den Boom G. van Schayck C.P. van Mollen M.P. Tirimanna P.R. den Otter J.J. van Grunsven P.M. Buitendijk M.J. van Herwaarden C.L. van Weel C. Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA Am J Respir Crit Care Med 158 1998 1730-1738